Macquarie Group’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.01K Hold
324
﹤0.01% 1632
2025
Q1
$4.82K Hold
324
﹤0.01% 1680
2024
Q4
$4.29K Hold
324
﹤0.01% 1592
2024
Q3
$4.61K Sell
324
-1,045,547
-100% -$14.9M ﹤0.01% 1639
2024
Q2
$13.5M Sell
1,045,871
-1,200,878
-53% -$15.5M 0.02% 746
2024
Q1
$31.2M Sell
2,246,749
-199,193
-8% -$2.77M 0.04% 574
2023
Q4
$34.9M Sell
2,445,942
-1,313,556
-35% -$18.7M 0.04% 541
2023
Q3
$58.2M Sell
3,759,498
-71,257
-2% -$1.1M 0.07% 357
2023
Q2
$60.2M Sell
3,830,755
-77,980
-2% -$1.23M 0.07% 370
2023
Q1
$64.4M Buy
3,908,735
+72,745
+2% +$1.2M 0.08% 334
2022
Q4
$59.8M Sell
3,835,990
-158,054
-4% -$2.47M 0.07% 377
2022
Q3
$51.8M Sell
3,994,044
-73,946
-2% -$959K 0.06% 410
2022
Q2
$57.1M Sell
4,067,990
-153,391
-4% -$2.15M 0.06% 404
2022
Q1
$60.5K Buy
4,221,381
+478,256
+13% +$6.85K 0.05% 458
2021
Q4
$51M Sell
3,743,125
-953,998
-20% -$13M 0.04% 516
2021
Q3
$76.9M Sell
4,697,123
-43,589
-0.9% -$714K 0.07% 386
2021
Q2
$79.8M Buy
4,740,712
+439,437
+10% +$7.4M 0.07% 378
2021
Q1
$78.5M Buy
4,301,275
+36,500
+0.9% +$666K 0.11% 225
2020
Q4
$77.6M Buy
4,264,775
+290,037
+7% +$5.28M 0.11% 201
2020
Q3
$70.9M Sell
3,974,738
-220,343
-5% -$3.93M 0.12% 182
2020
Q2
$75.2M Sell
4,195,081
-844,716
-17% -$15.1M 0.13% 162
2020
Q1
$76.5M Sell
5,039,797
-69,622
-1% -$1.06M 0.16% 122
2019
Q4
$101M Sell
5,109,419
-191,217
-4% -$3.77M 0.14% 119
2019
Q3
$91.2M Sell
5,300,636
-205,467
-4% -$3.53M 0.15% 118
2019
Q2
$97.5M Buy
5,506,103
+724,835
+15% +$12.8M 0.16% 110
2019
Q1
$97.4M Buy
+4,781,268
New +$97.4M 0.17% 106